BridgeMD
Tests treatment safety and results for Sarcopenia
Official title Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With Sarcopenia
ClinicalTrials.gov ID: NCT05431010
What this study is testing
- What it's testing
- Introduction: The efficacy of existing therapies for the treatment of sarcopenia is still not satisfactory. Therefore, this randomized controlled, assessor-blinded study was designed to investigate the efficacy and safety of electroacupuncture(EA) therapy in elderly patients with sarcopenia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 95
You may be able to join if
- 60 years ≤ age ≤ 95 years, male or female;
- Patients are able to walk and communicate independently, and can complete required rehabilitation training;
- Patients meet the diagnostic criteria proposed by the Asian Working Group for Sarcopenia(AWGS);
- Patients volunteer to participate in this study and sign the informed consent.
You likely can't join if
- Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system;
- Patients with severe mental illness, cognitive impairment, and disorientation;
- Patients have trauma and unsuitable for sports;
- Patients with electronic devices or metal objects implanted in the body;
- Patients can't complete the required rehabilitation training;
- Patients cannot receive EA treatment due to any reasons
See the full eligibility criteria
- 60 years ≤ age ≤ 95 years, male or female;
- Patients are able to walk and communicate independently, and can complete required rehabilitation training;
- Patients meet the diagnostic criteria proposed by the Asian Working Group for Sarcopenia(AWGS);
- Patients volunteer to participate in this study and sign the informed consent.
- Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system;
- Patients with severe mental illness, cognitive impairment, and disorientation;
- Patients have trauma and unsuitable for sports;
- Patients with electronic devices or metal objects implanted in the body;
- Patients can't complete the required rehabilitation training;
- Patients cannot receive EA treatment due to any reasons
- Patients are participating in other drugs, acupuncture and massage trials.
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 95 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.